WestGene
Pioneering the future of mRNA therapeutics and adjuvants through innovative research, development, and manufacturing.
Pioneering the future of mRNA therapeutics and adjuvants through innovative research, development, and manufacturing.
WestGene is a biopharmaceutical startup, founded in 2021, that is pioneering the future of mRNA therapeutics and adjuvants through innovative research, development, and manufacturing. The company's mission is to focus on the research and development, manufacturing, and sales of mRNA therapeutics and adjuvants in the biopharma and pharmaceutical industries. The most recent milestone for WestGene is the CNY300.00M Series A investment on 20 June 2023, which was led by 盈科创新资产管理有限公司, Huaxin Capital, and Sichuan Huiyuan. This substantial investment signals confidence in WestGene's potential and demonstrates strong support from prominent investors in the biopharmaceutical sector. With this backing, WestGene is well-positioned to continue its groundbreaking work in the field of mRNA therapeutics and adjuvants.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series A | CNY300.00M | 3 |
|
20 Jun 2023 |
No recent news or press coverage available for WestGene.
We care about your data, and we'd love to use cookies make your experience better.